Last quarter (Q2 2025), Enveric Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Enveric Biosciences's net income was $-2.52M. See Enveric Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -337.49K	$ -408.03K	$ -435.20K	$ -681.61K	$ -120.87K
Operating Expenses	$ 9.29M	$ 16.04M	$ 19.53M	$ 25.94M	$ 5.62M
Depreciation and Amortization	$ 337.49K	$ 408.03K	$ 435.20K	$ 681.61K	$ 120.87K
EBITDA	$ -9.23M	$ -16.85M	$ -19.52M	$ -55.74M	$ -6.30M
Operating Income	$ -9.63M	$ -16.45M	$ -19.96M	$ -64.62M	$ -5.62M
Other Income/Expenses	$ 66.21K	$ -814.38K	$ 7.46M	$ 8.19M	$ -1.25M
Pretax Income	$ -9.57M	$ -17.26M	$ -19.96M	$ -56.43M	$ -6.86M
Net Income	$ -9.57M	-	$ -18.47M	$ -48.98M	$ -6.39M
Per Share Metrics
Basic EPS	$ -228.48	$ -97.08	$ -87.72	$ -1.24K	$ -666.00
Diluted EPS	$ -228.48	$ -97.08	$ -156.00	$ -1.24K	$ -666.00
Weighted Average Shares Outstanding	41.91K	210.63K	210.63K	39.36K	9.59K
Weighted Average Shares Outstanding (Diluted)	41.91K	179.92K	173.19K	39.36K	9.59K

Currency in USD

Enveric Biosciences Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing